ASCOT-LLA: questions about the benefits of atorvastatin.
作者信息
Drummond G A
出版信息
Lancet. 2003 Jun 7;361(9373):1987-8. doi: 10.1016/s0140-6736(03)13563-5.
Abstract
摘要
相似文献
1
ASCOT-LLA: questions about the benefits of atorvastatin.盎格鲁-斯堪的纳维亚心脏结局试验-降脂治疗：关于阿托伐他汀益处的疑问。
Lancet. 2003 Jun 7;361(9373):1987-8. doi: 10.1016/s0140-6736(03)13563-5.
2
ASCOT-LLA: questions about the benefits of atorvastatin.盎格鲁-斯堪的纳维亚心脏结局试验-降脂治疗研究：关于阿托伐他汀益处的疑问。
Lancet. 2003 Jun 7;361(9373):1985-6; author reply 1986-7. doi: 10.1016/s0140-6736(03)13558-1.
3
ASCOT-LLA: questions about the benefits of atorvastatin.
Lancet. 2003 Jun 7;361(9373):1986; author reply 1986-7. doi: 10.1016/S0140-6736(03)13559-3.
4
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.盎格鲁-斯堪的纳维亚心脏结局试验降脂组：试验结束后2年的延长观察
Eur Heart J. 2008 Feb;29(4):499-508. doi: 10.1093/eurheartj/ehm583. Epub 2008 Jan 5.
5
ASCOT-LLA: questions about the benefits of atorvastatin.盎格鲁-斯堪的纳维亚心脏终点试验-降脂治疗协作组研究：关于阿托伐他汀益处的疑问。
Lancet. 2003 Jun 7;361(9373):1986; author reply 1986-7. doi: 10.1016/S0140-6736(03)13560-X.
6
Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.盎格鲁-斯堪的纳维亚心脏结局试验中抗高血压治疗及阿托伐他汀的获益：降脂治疗组扩展研究
J Hypertens. 2009 May;27(5):947-54. doi: 10.1097/HJH.0b013e328326cb1a.
7
ASCOT-LLA: questions about the benefits of atorvastatin.盎格鲁-斯堪的纳维亚心脏结局试验-降脂治疗协作组：关于阿托伐他汀益处的疑问。
Lancet. 2003 Jun 7;361(9373):1987. doi: 10.1016/S0140-6736(03)13562-3.
8
Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.阿托伐他汀与氨氯地平联合治疗在ASCOT-LLA研究中显示出益处。
Cardiovasc J S Afr. 2007 Jan-Feb;18(1):43-4.
9
The nature of the statins.他汀类药物的性质。
Circulation. 2000 Feb 29;101(8):E89. doi: 10.1161/01.cir.101.8.e89.
10
Statins for patients with type 2 diabetes.用于2型糖尿病患者的他汀类药物。
Lancet. 2004;364(9449):1933; author reply 1933. doi: 10.1016/S0140-6736(04)17462-X.
Zotero 插件